Introduction
Migration of vascular smooth muscle cells (VSMC) from the media to the intima is a critical event in atherosclerosis and in restenosis following angioplasty
Cell Culture
Human aortic vascular smooth muscle cells (HASMC) were obtained from Cambrex Corporation (East Rutherford, NJ). Passages 5 to 8 HASMC at 70% to 80% confluence were growth arrested by incubation in medium with 0.3% fetal bovine serum (FBS) for 24 hours before use. Rat aortic vascular smooth muscle cells (RASM) were isolated from the aorta of 200 − 250 g male Sprague-Dawley rats and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% calf serum as described previously 12) . Passages 10 to 15 RASM at 70% to 80% confluence were growth arrested by incubation in DMEM with 0.1% calf serum for 24 hours before use.
Chemotaxis and Haptotaxis assay
VSMC migration was examined in a modified Boyden Chamber Assay (Greiner Bio-one; Frickenhausen, Germany). For haptotaxis experiments, a polycarbonate membrane filter (pore size, 8 m) was coated with type collagen (50 g/mL) for one hour at 37 and then rinsed with phosphate-buffered saline (PBS). The upper chambers were placed into the lower chamber containing migration medium with or without platelet-derived growth factor (PDGF)-BB (10 ng/mL) to induce chemotaxis. Subconfluent VSMC were trypsinized, washed and resuspended in media containing 0.3% FBS. A cell suspension (0.5 10 4 cells) was added to the upper chamber of the Boyden system and allowed to migrate for 8 hr at 37 . Non-migratory cells were removed from the top filter surface with a cotton swab. Migrated cells, attached to the bottom surface, were washed with PBS, fixed, stained with Diff-Quick staining solution (Sysmex Kobe, Japan), and counted in 5 different microscopic fields. -galactosidase-positive cells were stained with X-gal as a substrate, and counted in 5 different fields. The experiments were repeated at least three times and the results were averaged for each experiment.
In Vitro Wound Healing Assay
A confluent cellular monolayer was wounded by manually scraping with a sterilized pipette, different doses of nifedipine (3, 10, 30 and 100 M) were added to the medium, and cells were allowed to migrate for 24 hours. The percentage of recovered distance between the nuclei of cells moving forward 24 h later relative to the distance between two rims in the cleared field at the beginning was taken as the index.
Immunoprecipitation and Western Blot Analysis
Immunoprecipitation and Western blot analysis wee performed as described previously 13) . In brief, growth-arrested VSMC were stimulated with PDGF-BB (10 ng/mL) at the indicated time points in each experiment. Cells were lysed in radioimmunoprecipitation assay (RIPA) lysis buffer (20 mM Tris [pH 7.8], 25 mM ethylenediaminetetraacetic acid (EDTA), 1% Triton-X, 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholic acid (DOC), 1 mM Na3VO4, 10 g/mL leupeptin, and 1 mM phenylmethanesulphonylfluoride (PMSF)). Cell lysates were prepared by scraping, sonication and centrifugation. Lysates containing an equal amount of proteins were pre-cleared and incubated with antibodies overnight at 4 . Antibodies complexes were collected by incubation with protein G-agarose as the monoclonal antibody and protein-A agarose as the polyclonal antibody. Precipitates were washed in lysis buffer and resuspended in SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer. Samples were separated by SDS-PAGE and transferred to nitrocellulose membranes. The blots were incubated with a primary antibody, and relative protein concentration was visualized using the ECL system (Amersham-Pharmacia Co., UK). Images were captured using Adobe Photoshop (Version 8.0; Pantone, Inc., USA), and the band intensities were quantified using Image J (NIH).
Immunofluorescence
Cells were plated on glass coverslips, fixed with 4% paraformaldehyde for 10 minutes, washed once with PBS, and permeabilized with 0.1% Triton-X 100 in PBS for 5 min. After another washing step with PBS, cells were incubated with FITC-phalloidin (Sigma) in 1% bovine serum albumin in PBS for 30 minutes at 37 . After cells were washed with PBS, cover glasses were mounted in VECTASHIELD mounting reagents (Vector Laboratories, Burlingame, CA) and visualized using fluorescence microscopy.
Plasmid and Small Interfering RNA (siRNA) Transfection
The plasmid for kinase-inactive (KI) Src was a generous gift from Dr. S. Courtneidge (Sugen, Inc.; San Francisco, USA). RASM (1.25 10 5 cells) were seeded in 6-well culture dishes overnight. For the co-transfection experiment with KI-Src and -galactosidase, Fugene-6 (Roche Applied Science, Indianapolis, IN) was used as a transfection reagent according to manufacturer's protocol. Cells were then serum deprived for 12 hours before the migration assay.
siRNA was purchased from Qiagen (Germany). The siRNA was transfected into HASMC with DharmaFECT1 (Dharmacon Research, Lafayette, CO) using the protocol provided by the manufacturer. 
Statistical Analysis
Results are expressed as the mean SEM. Difference between parameters were investigated using Mann-Whitney's U-test; p 0.05 was regarded as significant.
Results

Effect of Nifedipine on VSMC Chemotaxis and Haptotaxis
Nifedipine (10, 30, 100 M) inhibited PDGF-BB-induced HASMC chemotaxis in a dose-dependent manner (Fig. 1A) . Similarly, collagen-I-induced hapto- (A) HASMC were serum-starved for 24 hours, pretreated with different doses of nifedipine overnight, and then stimulated with PDGF-BB (10 ng/mL) for 5 minutes to observe circular dorsal ruffling (arrow indicates representative circular dorsal ruffling) (n 3), or (B) 10 minutes to observe lamellipodium formation (arrow indicates a representative lamellipodium) (n 4). Fixed cells were stained with FITC-phalloidin to visualize the actin cytoskeleton. Cells were counted in 5 different fields. Values are the mean SEM.
taxis was inhibited (6 5, 84 12%, 95 7%) by nifedipine (10, 30, 100 M, respectively; Fig. 1B) . Further, nifedipine potently inhibited scratch-induced HASMC migration in a dose-dependent manner (Fig. 1C) .
Effect of Nifedipine on PDGF-BB Induced Dorsal
Ruffling and Lamellipodium Formation HASMC were pretreated with different doses of nifedipine overnight and stimulated by PDGF-BB for 5 min to observe circular dorsal ruffling formation. As shown in Fig. 2A , PDGF-BB-induced dorsal ruffling formation in HASMC was inhibited by nifedipine in a dose-dependent manner. Similarly, nifedipine inhibited PDGF-induced lamellipodium formation in a dose-dependent manner (Fig. 2B) .
Role of c-Src in PDGF-BB-Induced VSMC Migration PDGF-BB increased c-Src activity within 30 seconds with a peak at 2 minutes in HASMC (Fig. 3A) . Treatment of VSMC with the Src family kinase inhibitor, PP2 (3, 10, 30 M), resulted in inhibition of PDGF-BB-induced chemotaxis in a dose-dependent manner (Fig. 3B) . Further, transfection of RASM with a plasmid for kinase-inactive Src inhibited VSMC chemotaxis by 59.5 7.4% (Fig. 3C) . Collagen-induced haptotaxis was also inhibited by PP2 and the expression of kinase-inactive Src (data not shown).
Effect of Nifedipine on PDGF-Induced Src Activation and Tyrosine Phosphorylation of its Substrates
Pretreatment of HASMC with nifedipine significantly reduced PDGF-induced Src activation in a dose-dependent manner (Fig. 4A) . Src phosphorylates several actin-associated proteins, such as Cas, paxillin, and cortactin 14, 15) . Tyrosine phosphorylation of these proteins has been reported to be involved in cell migration [16] [17] [18] . PDGF increased tyrosine phosphorylation of Cas, paxillin, and cortactin, and nifedipine significantly inhibited PDGF-induced phosphorylation of these proteins (Fig. 4B, C, D) . Nifedipine had no effect on protein expression of these molecules.
Pyk2 Regulates Src Activation and VSMC Migration
PDGF activated a Ca 2 -dependent tyrosine kinase, Pyk2, within 30 seconds (Fig. 5A) . siRNA against Pyk2 significantly inhibited PDGF-induced Src activation (Fig. 5B) . PDGF-induced migration was also inhibited by siRNA against Pyk2 (Fig. 5C) . Finally, treatment of HASMC with nifedipine resulted in a dose-dependent decrease in PDGF-induced activation of Pyk2, as reflected by the degree of tyrosine phosphorylation (Fig. 5D) .
Time after PDGF-BB 10 ng/mL stimulation (A) Src activation by PDGF-BB in VSMC. HASMC were serumstarved for 24 hours and stimulated with PDGF-BB (10 ng/mL) for different durations. Whole cell lysates were assayed by immunoblot using phospho-Src antibody (pY-416) to determine Src activity. The same amounts of cell lysates were assayed by immunoblot with anti-Src antibody for total Src protein. p 0.05 vs. time 0 (n 3) (B) HASMC were serum-starved for 24 hours and seeded in the upper Boyden chamber. PDGF-BB (10 ng/mL) was then added to the lower chamber with or without different doses of PP2. (C) RASM were co-transfected with plasmids for ?-galactosidase and kinase-inactive (KI) mutant Src. Six hours after transfection, RASM were serum deprived for 24 hours. Cells were seeded in the upper Boyden chamber before PDGF-BB (10 ng/mL) was added to the lower chamber. Cells were allowed to migrate through the membrane filter for 8 hours. Migrated cells were fixed, stained with X-gal and counted in 5 different microscopic fields. In all experiments, values are the mean SEM of at least three independent experiments.
Discussion
The present study demonstrated that nifedipine inhibited the migration of human VSMC. Inhibition of PDGF-induced Src kinase activation by a Src family kinase inhibitor or the expression of kinase-inactive Src attenuated VSMC migration. Nifedipine inhibited PDGF-induced Src activation, phosphorylation of cytoskeleton-associated Src substrates, and dorsal membrane ruffling, which is a phenomenon involved in cell motility. PDGF-induced activation of the calcium-dependent tyrosine kinase, Pyk2, was also inhibited by nifedipine, and siRNA against Pyk2 inhibited PDGF-induced Src activation and VSMC migration. These results suggest that nifedipine inhibits VSMC migration via inhibition of the Pyk2-Src axis and Srcdependent actin-cytoskeletal remodeling. Nifedipine inhibited PDGF-induced chemotaxis, collagen-induced haptotaxis, and wound-induced migration of VSMC. Since haptotaxis and wound-induced migration primarily involve integrin-induced signaling, these data indicate that nifedipine inhibits the common signaling mechanisms involved in VSMC migration 19) . We previously reported that Src is required for the tyrosine phosphorylation of actin-associated proteins, Cas, paxillin, and tensin, which also mediate ; however, data from other investigators suggest that the role of Src in cell migration may vary according to cell type and stimuli [20] [21] [22] . In the present study, PP2 and KI-Src inhibited VSMC migration, indicating that Src kinase activity mediates VSMC migration. Nifedipine potently inhibited PDGF-induced Src activation and tyrosine phosphorylation of Cas, paxillin, and cortactin, all of which have been implicated in cell migration [16] [17] [18] . Indeed, Kyaw and colleagues reported that Cas is involved in Anginduced VSMC migration 23) , and we previously used RNA interference techniques to demonstrate that Cas, cortactin, and paxillin are required for VSMC migration (unpublished data). Thus, the present data suggest that nifedipine inhibits VSMC migration via the inhibition of Src activation.
The present study also demonstrated that nifedipine inhibited PDGF-induced circular dorsal ruffling and lamellipodium formation. Circular dorsal ruffles form in response to growth factor stimulation in various cell types. Circular dorsal ruffles and lamellipodia are intimately linked, and both are thought to be highly involved in cell migration 24) . The precise mechanism by which nifedipine inhibits PDGFinduced circular dorsal ruffling and lamellipodium formation is not known. Ridley and colleagues reported that dorsal ruffling and lamellipodium formation both involve Rac 25) . Further, Gu and colleagues reported that Cas is required for laminin-10/11-induced Rac activation and cell migration 26) . Based on data from the present study, nifedipine may inhibit these cytoskeletal-remodeling processes via inhibition of the SrcCas-Rac pathway.
Pyk2/CADTK is a non-receptor and Ca 2 -dependent tyrosine kinase that was rapidly activated by PDGF in the present study 27) . Further, nifedipine significantly inhibited PDGF-induced Pyk2 activation, and siRNA against Pyk2 resulted in decreased PDGFinduced Src activation and VSMC migration. Although we did not show evidence that Pyk2 is a direct target of nifedipine, these data suggest that modulation of this Ca 2 -dependent kinase may be a major mechanism (upstream of Src) by which nifedipine acts to inhibit VSMC migration. Indeed, we and other investigators have shown that Pyk2 is involved in Src activation in response to other stimuli 28, 29) . Pyk2 has been also shown to be involved in trophic responses and signaling, such as protein synthesis and activation of ERK, Akt and P70 S6 kinase 30, 31) . ;therefore, nifedipine may exhibit antiatherogenic effects via the inhibition of Pyk2 and its downstream molecules 32) . In the present study, overnight treatment with nifedipine was required for full inhibition of PDGFinduced activation of Src and Pyk2 and migration. PDGF induces rapid Ca 2 mobilization from intracellular stores and sustained Ca 2 entry, which is not blocked by CCBs, or only partially, if at all 33, 34) . ;however, slow CCBs-sensitive Ca 2 influx is required to refill intracellular Ca 2 stores 35, 36) . Thus, it is possible that nifedipine inhibits PDGF-induced with Ca 2 -mobilization by gradually depleting intracellular Ca 2 stores, and interferes Ca 2 dependent intracellular signaling events.
In summary, we demonstrated that nifedipine interferes with VSMC migration via inhibition of the Pyk2-Src axis and inhibition of actin remodeling processes, including membrane ruffling and lamellipodium formation. These findings may provide new insights into the mechanisms of antiatherogenic effects of CCBs.
